Sharekhan

Rossari Biotech Ltd

Thu 7/05/2026,15:58:54 NSE: ROSSARI

₹ 539.30 48.90 (9.97%)
BUY NOW Buy Rossari Biotech Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Rossari Biotech Ltd

Thu 7/05/2026,16:1:0

Rossari Biotech Ltd

Thu 7/05/2026,15:58:54 | NSE : ROSSARI

₹ 539.3048.90 (9.97%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 498.25

Previous Close

₹ 490.40

Volume

1804870

Mkt Cap ( Rs. Cr)

₹2987.27

High

₹ 557.40

Low

₹ 492.05

52 Week High

₹ 766.00

52 Week Low

₹ 375.00

Book Value Per Share

₹ 231.78

Dividend Yield

0.10

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Rossari Biotech Ltd

Your Vote -

Buy

28.55%

Hold

46.22%

Sell

25.23%

28.55%

662 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

539.30

487

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

487

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Rossari Biotech Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    4 May 2026, 7:06PM Intimation of Transcript of Q4 FY 26 for the Earnings Conference Call held on April 28, 2026.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    4 May 2026, 7:06PM Intimation of Transcript of Q4 FY 26 for the Earnings Conference Call held on April 28, 2026.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    28 Apr 2026, 8:58PM Audio recording of Earnings Conference Call for Q4 FY 26.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Apr 2026, 8:57PM Audio recording of Earnings Conference Call for Q4 FY26.

  • Rossari Biotech - Cessation

    28 Apr 2026, 8:41PM Intimation of completion of tenure of Ms. Aparna Sharma (DIN:07132341) as an Independent Director of the Company from the close of business hours of A

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Cessation

    28 Apr 2026, 8:06PM Intimation of completion of tenure of Ms. Aparna Sharma (DIN:07132341) as an Independent Director of the Company from the close of business hours of A

  • Rossari Biotech - Investor Presentation

    28 Apr 2026, 2:18PM Rossari Biotech Limited has informed the Exchange about Investor Presentation

  • Rossari Biotech - Press Release

    28 Apr 2026, 1:59PM Rossari Biotech Limited informed the Exchange regarding Press Release dated April 27, 2026 titled "" Rossari Biotech announces Q4 FY 26 results"".

  • Rossari Biotech - Copy of Newspaper Publication

    28 Apr 2026, 1:46PM Newspaper Publication of extract of Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31, 2026.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Investor Presentation

    28 Apr 2026, 2:17PM Intimation of Q4 FY26- Earnings Presentation.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    28 Apr 2026, 1:56PM Rossari Biotech Limited informed the Exchange regarding Press Release dated April 27, 2026 titled \ Rossari Biotech announces Q4 FY 26 results\.

  • Rossari Biotech - Updates

    27 Apr 2026, 6:39PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    27 Apr 2026, 6:38PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Outcome of Board Meeting

    27 Apr 2026, 6:34PM Appointment of Mr. Udeypaul Singh Gill (DIN:00004340), as an Additional Director designated as Non-Executive, Independent Director of the Company

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Change in Directorate

    27 Apr 2026, 6:34PM Appointment of Mr. Udeypaul Singh Gill (DIN: 00004340), as an Additional Director designated as Non-Executive, Independent Director of the Company.

  • Rossari Biotech - ESOP/ESOS/ESPS

    27 Apr 2026, 6:21PM Intimation of Allotment of 8250 Equity shares under Rossari Employee Stock Option Plan-2019.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    27 Apr 2026, 6:21PM Intimation of allotment of 8250 Equity shares under Rossari Employee Stock Option Plan - 2019.

  • Rossari Biotech - Corporate Action-Board approves Dividend

    27 Apr 2026, 6:13PM Board has recommended final dividend of 25% i.e. Re. 0.50/- per share on Equity shares of the face value of Rs. 2/- each for the Financial Year ended

  • Rossari Biotech - Dividend

    27 Apr 2026, 6:11PM Board has recommended final dividend of 25% i.e Re. 0.50/- per share on Equity shares of the face value of Rs. 2/- each for the Financial Year ended M

  • Rossari Biotech Q4 net profit jumps 69.13% at Rs 54.73 cr

    27 Apr 2026, 6:10PM The company reported standalone net profit of Rs 54.73 crore for the quarter ended March 31, 2026 as compared to Rs 32.36 crore in the same period las

  • Rossari Biotech - Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31,

    27 Apr 2026, 6:02PM Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026.

  • Rossari Biotech - Outcome of Board Meeting

    27 Apr 2026, 5:37PM Outcome of Board Meeting held on April 27, 2026.

  • Rossari Biotech - Board Meeting Outcome for Board Meeting Held On April 27, 2026

    27 Apr 2026, 5:41PM Outcome of Board Meeting held on April 27, 2026

  • Rossari Biotech - Updates

    23 Apr 2026, 9:57PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    23 Apr 2026, 9:56PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    21 Apr 2026, 10:39PM Intimation of Earnings Conference Call for investor and analyst on Tuesday, April 28, 2026 at 05:00 P.M. (IST).

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    21 Apr 2026, 10:37PM Intimation of Earnings Conference Call for investor and analyst on Tuesday, April 28, 2026 at 05:00 P.M. (IST).

  • Rossari Biotech - Board Meeting Intimation for Audited Financial Statements And Financial Results (Standalone And Consolidate

    18 Apr 2026, 8:09PM Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2026 ,inter alia, to consider and

  • Rossari Biotech has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    14 Apr 2026, 4:11PM As of March 2026, 68.15% is owned by Promoters and 31.85% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 63.64% and Fore

  • Rossari Biotech - Updates

    3 Apr 2026, 8:40PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulation 2015.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulation 2015

    3 Apr 2026, 8:39PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulation 2015.

  • Rossari Biotech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    3 Apr 2026, 7:31PM Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

  • Rossari Biotech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    3 Apr 2026, 7:31PM Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

  • Rossari Biotech - Capacity addition

    31 Mar 2026, 6:42PM Update on Capacity Addition at the Subsidiary.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    31 Mar 2026, 6:42PM Update on Capacity Addition at the Subsidiary.

  • Rossari Biotech - Trading Window

    25 Mar 2026, 8:01PM Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Rossari Biotech - Updates

    24 Mar 2026, 9:05PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    24 Mar 2026, 9:05PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Updates

    18 Feb 2026, 7:01PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    18 Feb 2026, 7:00PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech

    20 Oct 2022 , 10:21AM RBL has approved the incorporation of a wholly owned subsidiary in Bangladesh with an estimate aggregate Capital outlay of BDT 300 million (approximately Rs. 25 Crore). The Wholly Owned Subsidiary will enable the Company to expand the market for RBL products in Bangladesh. Positive for the stock

  • Rossari Biotech

    19 Jul 2021 , 10:22AM Rossari Biotech Limited (Rossari): The company has approved the acquisition of Tristar Intermediates Pvt. Ltd. As per the agreement, Rossari will be acquiring 100% of the equity share capital of Tristar Intermediates. 76% of the equity share capital will be acquired upon closure of the transaction, and the balance 24% over the next 3 years. The total enterprise value of the transaction is Rs. 120 crores. Rossari plans to fund the investment through cash on balance sheet and doesn’t intend to raise any debt for this acquisition. The transaction will add scale, provide cross-selling opportunities, and accelerate growth for Rossari, while significantly enhancing value creation in the longer term. The synergistic acquisition provides Rossari with enhanced portfolio of products, stronger presence in new & untapped international markets and access to newer technologies.

  • Rossari Biotech debuts at 58% premium

    23 Jul 2020 , 10:46AM Rossari Biotech lists at Rs. 670/Sh against the issue price of Rs. 425/Sh
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Rossari Biotech Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 1345.004 1107.318 1015.386 923.612 784.524
Liabilities 1345.004 1107.318 1015.386 923.612 784.524
Equity 11.077 11.073 11.049 11.031 11.011
Gross Profit 208.335 186.235 161.254 122.648 122.793
Net Profit 142.838 114.742 99.645 71.39 79.474
Cash From Operating Activities 58.729 92.198 73.918 113.66 33.116
NPM(%) 8.15 8.01 8.28 7.32 7.4
Revenue 1752.066 1431.628 1202.91 975.172 1072.844
Expenses 1543.731 1245.393 1041.656 852.524 950.051
ROE(%) 11.12 8.93 7.76 5.56 6.19

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
0.5 25 0.09 504.2
20 Jun 2025 0.5 25 0.09 699.35
16 Aug 2024 0.5 25 0.09 780.3
24 May 2023 0.5 25 0.09 695.5
07 Jul 2022 0.5 25 0.09 888.75
08 Sep 2021 0.5 25 0.09 1282.15

Peers

Other companies within the same industry or sector that are comparable to Rossari Biotech Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sameera Agro And Infra Ltd 8.10 -2.99 3.32 642.65 24.38 0.00
Shreeoswal Seeds and Chemicals Ltd 12.95 4.02 21.23 4935.72 19.29 0.00
GRM Overseas Ltd 164.54 -0.82 46.35 3237.60 146.22 0.00
Jain Irrigation Systems Ltd 36.00 5.66 163.64 37292.84 23.46 0.00

Company Info

The Promoters, commenced the specialty chemicals business on March 6, 2003, as a partnership firm in the name of `Rossari Labtech', having Mr. Edward Menezes and Mr. Sunil Chari as partners. Subsequently, on December 5, 2003, the name of the partnership firm was changed to `Rossari Biotech', and the business of the partnership was changed to that of manufacturing, purchase, sale, import, export and otherwise to deal in enzymes, textile auxiliaries, applications and products of biotechnology for textiles, leather, paper, construction materials, pharmaceuticals etc. Further, on January 17, 2004, RBIPL was admitted as partner in Rossari Biotech. On April 1, 2009, Ms. Anita Menezes, Ms. Usha Chari, Ms. Jyotishna Chari and late Ms. Irene Menezes were admitted as partners in Rossari Biotech and on June 15, 2009, Mr. Mikhail Menezes was admitted as a partner in Rossari Biotech.Major events and milestones :2003- The Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India2004- Established the first manufacturing facility at Silvassa2009- Conversion of partnership firm into the Company- Incorporation of the Company- Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research2010- Forayed into animal health and nutrition products2013- Forayed into HPPC products2014- The Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari Private Limited-Recipient of Best Innovator Award 2014 by BIRAC Govt.Of India2015- Lease granted by GIDC to the Company for setting up the manufacturing facility at Dahej2017- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 14001:20152018- Entered into an exclusive purchasing agreement with Hindustan Unilever Limited2019-Rossari Biotech files Rs 700-cr IPO papers with Sebi2020- Completion of the Pre-IPO Placement2021-Rossari Biotech announces full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat.-Rossari Biotech Ltd was recently bestowed with the Goldern Peacock Award for Business Excellence 2021.-Rossari Biotech completed acquisition of 1st tranche of 76% stake of Tristar.2023-Bio Spectrum India Excellence Awards 2023 as the Bet Indian Industrial Enzymes Company.

The Promoters, commenced the specialty chemicals business on March 6, 2003, as a partnership firm in the name of `Rossari Labtech', having Mr. Edward Menezes and Mr. Sunil Chari as partners. Subsequently, on December 5, 2003, the name of the partnership firm was changed to `Rossari Biotech', and the business of the partnership was changed to that of manufacturing, purchase, sale, import, export and otherwise to deal in enzymes, textile auxiliaries, applications and products of biotechnology for textiles, leather, paper, construction materials, pharmaceuticals etc. Further, on January 17, 2004, RBIPL was admitted as partner in Rossari Biotech. On April 1, 2009, Ms. Anita Menezes, Ms. Usha Chari, Ms. Jyotishna Chari and late Ms. Irene Menezes were admitted as partners in Rossari Biotech and on June 15, 2009, Mr. Mikhail Menezes was admitted as a partner in Rossari Biotech.Major events and milestones :2003- The Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India2004- Established the first manufacturing facility at Silvassa2009- Conversion of partnership firm into the Company- Incorporation of the Company- Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research2010- Forayed into animal health and nutrition products2013- Forayed into HPPC products2014- The Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari Private Limited-Recipient of Best Innovator Award 2014 by BIRAC Govt.Of India2015- Lease granted by GIDC to the Company for setting up the manufacturing facility at Dahej2017- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 14001:20152018- Entered into an exclusive purchasing agreement with Hindustan Unilever Limited2019-Rossari Biotech files Rs 700-cr IPO papers with Sebi2020- Completion of the Pre-IPO Placement2021-Rossari Biotech announces full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat.-Rossari Biotech Ltd was recently bestowed with the Goldern Peacock Award for Business Excellence 2021.-Rossari Biotech completed acquisition of 1st tranche of 76% stake of Tristar.2023-Bio Spectrum India Excellence Awards 2023 as the Bet Indian Industrial Enzymes Company.

Read More

Parent Organisation

Rossari Biotech Ltd.

Founded

10/08/2009

Managing Director

Mr.Sunil Chari

NSE Symbol

ROSSARIEQ

FAQ

The current price of Rossari Biotech Ltd is ₹ 539.30.

The 52-week high for Rossari Biotech Ltd is ₹ 557.40 and the 52-week low is ₹ 492.05.

The market capitalization of Rossari Biotech Ltd is currently ₹ 2987.27. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Rossari Biotech Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Rossari Biotech Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Rossari Biotech Ltd shares.

The CEO of Rossari Biotech Ltd is Mr.Sunil Chari, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT